Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NASCOBAL 500 MCG NASAL SPRAY

cyanocobalamin
$171.7390per EA
High Outlier

Strength

500 ug/1

Manufacturer

Endo USA Inc.

NDC

49884027082

Classification

Brand

Dosage Form

SPRAY

Route

NASAL

Last Updated

7/23/2025

Active Ingredients

CYANOCOBALAMIN

Approval Type

New Drug (NDA)

FDA Application

NDA021642

On Market Since

8/13/2009

Pharmacological Classes

Vitamin B 12
Vitamin B12

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.4%

3Y

+1.1%

5Y

+10.7%

All

+80.0%

Generic Alternatives

Save up to 30%

1 alternative • Same active ingredient

CYANOCOBALAMIN 500 MCG SPRAY
Generic
45802049184•Padagis Israel Pharmaceuticals Ltd
$119.8998
Save 30%

Related Drugs

Same classification

CONCEPT OB CAPSULE
Brand
52747062030•U.S. Pharmaceutical Corporation
$0.8902
per EA
CONCEPT DHA CAPSULE
Brand
52747062130•U.S. Pharmaceutical Corporation
$1.0560
per EA
NESTABS TABLET
Brand
50967021990•WOMENS CHOICE PHARMACEUTICALS LLC
$1.8995
per EA
STROVITE ONE CAPLET
Brand
00642020790•Exeltis USA, Inc.
$2.6229
per EA
PRENATE ENHANCE SOFTGEL
Brand
75854030930•Avion Pharmaceuticals, LLC
$3.8708
per EA
VITAFOL-ONE CAPSULE
Brand
00642007030•Exeltis USA, Inc.
$4.4841
per EA
VITAFOL FE PLUS SOFTGEL
Brand
00642747330•Exeltis USA, Inc.
$4.5034
per EA
VITAFOL ULTRA SOFTGEL
Brand
00642009330•Exeltis USA, Inc.
$4.5243
per EA
PRENATE ELITE TABLET
Brand
75854031430•Avion Pharmaceuticals, LLC
$4.8706
per EA
PRENATE ESSENTIAL SOFTGEL
Brand
75854031330•Avion Pharmaceuticals, LLC
$4.8884
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy